Print

Pacira Pharmaceuticals, Inc. Reports 2012 Financial Results  
3/7/2013 6:23:50 AM

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced consolidated 2012 financial results and provided updates on the commercial launch of EXPAREL®(bupivacaine liposome injectable suspension) for postsurgical pain in the United States.
//-->